Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 12INDUSTRY 5NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 26Rectal Neoplasms 19Colonic Neoplasms 18Leukemia 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma 11Stomach Neoplasms 9Burkitt Lymphoma 7Pancreatic Neoplasms 5Leukemia, Biphenotypic, Acute 4Esophageal Neoplasms 4Adenocarcinoma Of Esophagus 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasm Metastasis 3Lymphoma, Large B-Cell, Diffuse 3Dendritic Cell Sarcoma, Interdigitating 3Lymphoma, Mantle-Cell 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thrombocytopenia 1Sarcoma 1Rhabdoid Tumor 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neutropenia 1Metastatic Small Intestinal Adenocarcinoma 1Metastatic Pancreatic Adenocarcinoma 1Medulloblastoma 1Leukemia, Myelomonocytic, Juvenile 1Hydatidiform Mole 1

Interventions

Ultrasonography 1Preoperative Exercise 1Oxaliplatin 1Leucovorin 1Fluorouracil 1AMG 337 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Gastrointestinal Neoplasms × Leucovorin × Clear all
NCT02344810 2023-05-25

C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer

Eastern Cooperative Oncology Group

Phase 1/2 Withdrawn
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gastrointestinal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡